Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab

[4] Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone

[5] Cyclophosphamide ,
Dexamethasone ,
Bortezomib ,
Cyclophosphamide ,
Daratumumab 💬

Name	Other Names
Cyclophosphamide	Cyclophosphamide (USP) Cyclophosphamide hydrate (JP18) Cytoxan (TN) Neosar (TN)
Dexamethasone	Dexamethasone (JP18/USP/INN) Decadron (TN) Maxidex (TN) DEXTENZA DEXYCU HEMADY OZURDEX DEXAMETHASONE 6-DAY DEXAMETHASONE INTENSOL TAPERDEX 12-DAY TAPERDEX 6-DAY TAPERDEX 7-DAY
Bortezomib	Bortezomib (JAN/USAN/INN) Velcade (TN)
Cyclophosphamide	Cyclophosphamide (INN) Cyclophosphamide (TN) Cytoxan (TN)
Daratumumab	Daratumumab (USAN) Daratumumab (genetical recombination) (JAN) Darzalex (TN)

[3] CD38,
NR3C1,
PSMB5 💬

[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬

[1] 28 💬